Carcinogenesis, Vol. 21, No. 4, 735-740,
April 2000
© 2000 Oxford University Press
Carcinogenesis |
Induction of mammalian cell transformation and genotoxicity by 2-methoxyestradiol, an endogenous metabolite of estrogen
Department of Pharmacology, The Nippon Dental University, School of Dentistry at Tokyo, Tokyo 102-8159, Japan and
1 Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Science, PO Box 12233, Research Triangle Park, NC 27709, USA
2-Methoxyestradiol (2-MeOE2) is an endogenous metabolite of 17ß-estradiol and a proposed inhibitor of tumor growth and angiogenesis. However, 2-MeOE2 is also an inhibitor of microtubule assembly and other microtubule inhibitors, e.g. colcemid and diethylstilbestrol, induce aneuploidy and cell transformation in cultured mammalian cells. To assess the in vitro carcinogenicity and related activity of 2-MeOE2, the abilities of this metabolite to induce cell transformation and genetic effects were studied simultaneously using Syrian hamster embryo (SHE) fibroblasts. Growth of these cells was reduced by treatment with 2-MeOE2 at 0.1–1.0 µg/ml in a concentration-dependent manner. Treatment of SHE cells with 2-MeOE2 at 0.3 or 1.0 µg/ml for 2–48 h also resulted in a concentration- and treatment time-related increase in the mitotic index and the percentage of multinucleated cells. Treatment with 2-MeOE2 at 0.1–1.0 µg/ml for 48 h induced a statistically significant increase in the frequencies of morphological transformation of SHE cells in a concentration-dependent manner. A statistically significant increase in the frequencies of somatic mutations at the Na+/K+ ATPase or hprt locus was also observed in cells treated with 2-MeOE2 for 48 h at 0.1 or 0.3 µg/ml, respectively. Treatment of SHE cells with 2-MeOE2 at 0.3 or 1.0 µg/ml for 24 h induced chromosome aberrations, mainly breaks, exchanges and chromosome pulverization. The incidence of chromosome aberrations was not affected by co-treatment with 
-naphthoflavone, an inhibitor of 2-hydroxylase that inhibits oxidative conversion of 2-MeOE2 to 2-hydroxyestradiol, but the incidence was slightly increased by co-treatment with L-ascorbic acid. Numerical chromosomal changes in the near diploid range and in the tetraploid and near tetraploid ranges were also detected in 2-MeOE2-treated cells. These findings indicate that 2-MeOE2 has cell transforming and genotoxic activities in cultured mammalian cells and potential carcinogenic activity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. D. Yager and N. E. Davidson Estrogen Carcinogenesis in Breast Cancer N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282. [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Ciobanu, V. Luu-The, C. Martel, F. Labrie, and D. Poirier Inhibition of Estrone Sulfate-induced Uterine Growth by Potent Nonestrogenic Steroidal Inhibitors of Steroid Sulfatase Cancer Res., October 1, 2003; 63(19): 6442 - 6446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dawling, N. Roodi, and F. F. Parl Methoxyestrogens Exert Feedback Inhibition on Cytochrome P450 1A1 and 1B1 Cancer Res., June 15, 2003; 63(12): 3127 - 3132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dawling, N. Roodi, R. L. Mernaugh, X. Wang, and F. F. Parl Catechol-O-Methyltransferase (COMT)-mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms Cancer Res., September 1, 2001; 61(18): 6716 - 6722. [Abstract] [Full Text] [PDF]
|
|